Katana Boyd
Family · Cape Girardeau, MONPI 1073052296
Payments from drug & device makers
Across 222 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$421
- Collegium Pharmaceutical, Inc.$246
- Pfizer$214
- Biohaven Pharmaceutical Holding Company Ltd.$145
- Amgen$127
- plus $717 from 22 others
What the payments were for
- Food & beverage$4,158100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 97 | $2,288 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 31 | $421 |
| Collegium Pharmaceutical, Inc. | 15 | $246 |
| Pfizer | 20 | $214 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $145 |
| Amgen | 6 | $127 |
| Lilly USA, LLC | 4 | $71 |
| Valinor Pharma, LLC | 4 | $70 |
| Impel Pharmaceuticals Inc. | 3 | $58 |
| Scilex Pharmaceuticals Inc. | 3 | $51 |
| AstraZeneca | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 3 | $44 |
| Novartis | 2 | $42 |
| Abbott | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Bayer | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Amneal Pharmaceuticals LLC | 2 | $25 |
| Lundbeck LLC | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Si-bone, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| GSK | 1 | $16 |
| Merck | 1 | $15 |
| Protega Pharmaceutials Inc | 1 | $15 |
How this compares
$4,158 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 22 | $23,934 |
| OzempicSemaglutide | 14 | $13,159 |
| Diclofenac Sodium | 23 | $2,436 |
| Gabapentin | 70 | $828 |
| Duloxetine Hcl | 36 | $777 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $721 |
| Celecoxib | 22 | $379 |
| Ibuprofen | 38 | $299 |
| Pantoprazole Sodium | 18 | $242 |
| Tizanidine Hcl | 31 | $239 |
| Amitriptyline Hcl | 15 | $216 |
| Ropinirole Hcl | 26 | $213 |
| Baclofen | 32 | $208 |
| Topiramate | 39 | $192 |
| Cyclobenzaprine Hcl | 32 | $188 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $214 | $23,93422 claims |
| Novo NordiskOzempic | $20 | $13,15914 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $25 | $8621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.
Other family in Cape Girardeau
- Heather MillerCape Girardeau$16K
- Michele TanzCape Girardeau$13K
- Christina CossouCape Girardeau$13K
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.